Targeting Parathyroid Hormone Level in Diabetic Patients With Stage 3 to 5 Chronic Kidney Disease: Does Metabolic Syndrome Matter?
To access this article, please choose from the options below
PII: S1051-2276(10)00109-3
doi:10.1053/j.jrn.2010.04.006
© 2011 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.

